Jacobus Pfisterer

A Phase 3 Trial of Bevacizumab in Ovarian Cancer

Timothy Perren, Ann Marie Swart, Jacobus Pfisterer et al. · New England Journal of Medicine · 2011 · 2.1K citations · Full text

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

Andreas du Bois, Eric Pujade‐Lauraine, Philipp Harter et al. · Cancer · 2009 · 1.6K citations · Full text

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Amit M. Oza, Adrian Cook, Jacobus Pfisterer et al. · The Lancet Oncology · 2015 · 845 citations · Full text

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)

Andreas du Bois, Michael Quinn, Tate Thigpen et al. · Annals of Oncology · 2005 · 465 citations

Medicine, Cancer Management, Reproductive Health +9

The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy

Lars Hanker, Sibylle Loibl, Nicole Burchardi et al. · Annals of Oncology · 2012 · 333 citations

Medicine, Primary Taxane/platinum-based Therapy, Gynecology +8